New study aims to spot warning signs of deadly infections in kids
NCT ID NCT06260345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 3,000 children hospitalized with severe bacterial infections to understand what makes them so dangerous. Researchers will collect data on the bacteria, the children's health, and the care they receive. The goal is to find risk factors and early warning signs so that future infections can be prevented or treated faster.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and prevent severe bacterial infections in children, potentially saving lives.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly cure or treat any child, and results may take years to influence care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 3,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2024
- Expected to finish
-
Jan 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Children under 18 ages, with severe communautary invasive bacterial infections, hospitalized in pediatric intensive care unit.
- Ages
-
Up to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age \<18 years (only hospitalized children) * Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment). Exclusion Criteria: * Refusal by one of the parents or by Child in understanding age * Nosocomial infection
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hospitalized children are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Association Clinique Thérapeutique Infantile du val de Marne
RECRUITINGCréteil, 94600, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New study monitors infection risks in blood cancer patients on bispecific antibodies
- Could early antibiotic stop be safe for kids with cancer?
- New guidelines aim to cut unnecessary antibiotics in febrile babies
- New study aims to perfect antibiotic dosing for sickest kids
- French study tracks unusual rise in child mycoplasma infections
- New study tracks antifungal drug in sick kids